First M&A to reinvent pharmacies
Juno's mission is to reinvent family pharmacy, focusing on investing in our colleagues to provide the highest level of patient care and personal service. We aim to become the local pharmacy of choice by applying our core values of engagement, professionalism, trustworthiness, and efficiency to everything we do—whether with customers, suppliers, or within the community.
Mark Peatey, CEO of Juno Health, said:
"The Ashchem estate is one of the most respected pharmacy groups in Northern England. Ash Aggarwal built this business over 35 years by focusing on patient care and employing highly trained, patient-focused staff. We’re delighted to welcome Ashchem to Juno Health and look forward to working with our new colleagues to continue building a pharmacy network that delivers on our mission."
The Ashchem transaction is the first acquisition since Juno set up. In 2018, Bregal Freshstream Capital backed the Juno team to invest in scaling-up.
"Unlike many advisors and agents I found James to be a really refreshing change; he spent a long time listening and understanding me and we developed an excellent rapport. It’s not often that your professional advisors also become friends, but our relationship is a testament to the mutual respect we developed for each other.
"It was clear that James’ knowledge, experience and work ethic were second to none. He was always available 24/7 on the phone to support me or was quite happy to travel 6 hours to come and see me regularly.
"Honest and trustworthy with a great understanding of me and my business it was a pleasure to work with James and the outcome was superb.”
The Ashchem shareholder was advised by James Pugh, with legal support from Newcastle law firm Minscoffs.
We'd love to hear your story
Let's chat about your future plans. We can help you get clear on where your business journey is going.
